GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Medinet Co Ltd (TSE:2370) » Definitions » Return-on-Tangible-Asset

Medinet Co (TSE:2370) Return-on-Tangible-Asset : -22.35% (As of Mar. 2024)


View and export this data going back to 2003. Start your Free Trial

What is Medinet Co Return-on-Tangible-Asset?

Return-on-Tangible-Asset is calculated as Net Income divided by its average total tangible assets. Total tangible assets equals to Total Assets minus Intangible Assets. Medinet Co's annualized Net Income for the quarter that ended in Mar. 2024 was 円-1,366.4 Mil. Medinet Co's average total tangible assets for the quarter that ended in Mar. 2024 was 円6,113.2 Mil. Therefore, Medinet Co's annualized Return-on-Tangible-Asset for the quarter that ended in Mar. 2024 was -22.35%.

The historical rank and industry rank for Medinet Co's Return-on-Tangible-Asset or its related term are showing as below:

TSE:2370' s Return-on-Tangible-Asset Range Over the Past 10 Years
Min: -62.85   Med: -21.39   Max: -14.61
Current: -24.52

During the past 13 years, Medinet Co's highest Return-on-Tangible-Asset was -14.61%. The lowest was -62.85%. And the median was -21.39%.

TSE:2370's Return-on-Tangible-Asset is ranked better than
63.13% of 1546 companies
in the Biotechnology industry
Industry Median: -40.335 vs TSE:2370: -24.52

Medinet Co Return-on-Tangible-Asset Historical Data

The historical data trend for Medinet Co's Return-on-Tangible-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medinet Co Return-on-Tangible-Asset Chart

Medinet Co Annual Data
Trend Sep14 Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23
Return-on-Tangible-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only -23.35 -20.43 -16.00 -22.18 -25.01

Medinet Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Return-on-Tangible-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -26.34 -27.52 -28.69 -19.91 -22.35

Competitive Comparison of Medinet Co's Return-on-Tangible-Asset

For the Biotechnology subindustry, Medinet Co's Return-on-Tangible-Asset, along with its competitors' market caps and Return-on-Tangible-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Medinet Co's Return-on-Tangible-Asset Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Medinet Co's Return-on-Tangible-Asset distribution charts can be found below:

* The bar in red indicates where Medinet Co's Return-on-Tangible-Asset falls into.



Medinet Co Return-on-Tangible-Asset Calculation

Medinet Co's annualized Return-on-Tangible-Asset for the fiscal year that ended in Sep. 2023 is calculated as:

Return-on-Tangible-Asset=Net Income/( (Total Tangible Assets+Total Tangible Assets)/ count )
(A: Sep. 2023 )  (A: Sep. 2022 )(A: Sep. 2023 )
=Net Income/( (Total Assets - Intangible Assets+Total Assets - Intangible Assets)/ count )
(A: Sep. 2023 )  (A: Sep. 2022 )(A: Sep. 2023 )
=-1437.95/( (5976.374+5520.897)/ 2 )
=-1437.95/5748.6355
=-25.01 %

Medinet Co's annualized Return-on-Tangible-Asset for the quarter that ended in Mar. 2024 is calculated as:

Return-on-Tangible-Asset=Net Income/( (Total Tangible Assets+Total Tangible Assets)/ count )
(Q: Mar. 2024 )  (Q: Dec. 2023 )(Q: Mar. 2024 )
=Net Income/( (Total Assets - Intangible Assets+Total Assets - Intangible Assets)/ count )
(Q: Mar. 2024 )  (Q: Dec. 2023 )(Q: Mar. 2024 )
=-1366.396/( (6235.279+5991.12)/ 2 )
=-1366.396/6113.1995
=-22.35 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Return-on-Tangible-Asset, the net income of the last fiscal year and the average total tangible assets over the fiscal year are used. In calculating the quarterly data, the Net Income data used here is four times the quarterly (Mar. 2024) net income data.


Medinet Co  (TSE:2370) Return-on-Tangible-Asset Explanation

Return-on-Tangible-Asset measures the rate of return on the average total tangible assets (total assets minus intangible assets). Tangible means physical in nature. Intangible Assets are assets that are not physical in nature, and typically "derive their value from legal or intellectual rights." Return-on-Tangible-Asset measures a firm's efficiency at generating profits from its tangible assets. It shows how well a company uses what it has to generate earnings. Return-on-Tangible-Assets can vary drastically across industries. Therefore, Return-on-Tangible-Asset should not be used to compare companies in different industries.


Be Aware

Like ROE and ROA, Return-on-Tangible-Asset is calculated with only 12 months data. Fluctuations in the company’s earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. Return-on-Tangible-Asset can be affected by events such as stock buyback or issuance, and by a company’s tax rate and its interest payment. Return-on-Tangible-Asset may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).

Many analysts argue the higher return the better. Buffett states that really high Return-on-Tangible-Asset may indicate vulnerability in the durability of the competitive advantage.


Medinet Co Return-on-Tangible-Asset Related Terms

Thank you for viewing the detailed overview of Medinet Co's Return-on-Tangible-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Medinet Co (TSE:2370) Business Description

Traded in Other Exchanges
N/A
Address
2-3-12 Shin-Yokohama, Shin-Yokohama Square Building, 14 Floor, Kohoku-ku, Yokohama, JPN, 222-0033
Medinet Co Ltd is a Japan-based Contract Development and Manufacturing Organization (CDMO). The company is engaged in the research and development of regenerative medical products, investigational products, and specified cell products. MEDINET is a one-stop regenerative medicine and cell therapy solution provider. It provides value chain solutions including personnel training, facility and equipment design, facility operations and management, preparation of standard operating procedures, logistics network, information system, purchasing and production management, quality management solutions to medical institutions, research institutions, and biopharmaceutical companies.

Medinet Co (TSE:2370) Headlines

No Headlines